| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.98▼ | 0.97▼ | 0.97▼ | 0.98▼ | 1.02▼ |
| MA10 | 0.97▼ | 0.97▼ | 0.97▼ | 0.98▼ | 1.22▼ |
| MA20 | 0.97▼ | 0.97▼ | 0.98▼ | 1.02▼ | 1.07▼ |
| MA50 | 0.98▼ | 0.99▼ | 1.01▼ | 1.23▼ | 1.59▼ |
| MA100 | 1.01▼ | 1.02▼ | 1.07▼ | 1.07▼ | 1.54▼ |
| MA200 | 1.05▼ | 1.16▼ | 1.26▼ | 1.31▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | 0.002▲ | 0.003▲ | 0.003▲ | 0.017▲ |
| RSI | 45.132▼ | 46.312▼ | 45.369▼ | 40.050▼ | 42.805▼ |
| STOCH | 52.862 | 47.715 | 50.117 | 34.209 | 19.012▼ |
| WILL %R | -83.333▼ | -68.925 | -68.925 | -71.810 | -84.561▼ |
| CCI | -61.578 | -40.812 | -44.453 | -57.167 | -54.934 |
|
Friday, December 05, 2025 09:53 AM
This strategic filing with the FDA follows encouraging internal data and recent published studies supporting Nexalin’s frequency neurostimulator as a potential non-invasive therapy for cognitive ...
|
|
Friday, December 05, 2025 09:49 AM
Peer-reviewed case report published in The American Journal on Addictions highlights significant clinical improvement and sustained abstinence following Nexalin’s non-invasive therapyHOUSTON, TX, Nov.
|
|
Wednesday, December 03, 2025 05:10 AM
The meeting focused on Nexalin’s proposed clinical development plan and overall regulatory strategy for the Gen-2 SYNC console in Alzheimer’s disease. As part of the interaction, the Company and the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/12/25 | 0.9692 | 0.9692 | 0.9692 | 0.9692 | 25,822 |
| 10/12/25 | 0.98 | 0.998 | 0.949 | 0.978 | 74,600 |
| 09/12/25 | 0.96 | 1.01 | 0.93 | 0.998 | 100,100 |
| 08/12/25 | 1.00 | 1.00 | 0.9512 | 0.9606 | 140,764 |
| 05/12/25 | 1.00 | 1.0193 | 0.966 | 0.97 | 59,712 |
| 04/12/25 | 0.9613 | 0.991 | 0.9613 | 0.963 | 88,987 |
| 03/12/25 | 0.9675 | 1.03 | 0.9627 | 0.9852 | 83,146 |
| 02/12/25 | 0.91 | 0.9905 | 0.91 | 0.9701 | 136,733 |
| 01/12/25 | 1.00 | 1.02 | 0.9201 | 0.9201 | 170,845 |
| 28/11/25 | 1.08 | 1.0983 | 1.065 | 1.08 | 28,674 |
|
|
||||
|
|
||||
|
|